VERA
Vera Therapeutics Inc
$13.71
Earnings Summary
Net Profits | $-20.16Mn |
Highlights
Net Profits:
Vera Therapeutics Inc’s net profit fell -35.74% since last year same period to $-20.16Mn in the Q2 2023. On a quarterly growth basis, Vera Therapeutics Inc has generated 32.24% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vera Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.84 |
EPS Estimate Current Year | -0.84 |
Highlights
EPS Estimate Current Quarter:
Vera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.84 - a 3.08% jump from last quarter’s estimates.
EPS Estimate Current Year:
Vera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.84.
Key Ratios
Key ratios of the Vera Therapeutics Inc post its Q2 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Vera Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Vera Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-11 | -0.86 | 0 | 100% |
2023-08-10 | -0.84 | 0 | 100% |
₹0 US Stocks a/c Opening Fee